Morten Thronæs1,2, Sunil X Raj3,4, Cinzia Brunelli3,5, Sigrun Saur Almberg4, Ola Magne Vagnildhaug3,4, Susanna Bruheim3, Birgit Helgheim3, Stein Kaasa3,4, Anne Kari Knudsen3,4. 1. European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway, NO 7491. morten.thrones@ntnu.no. 2. Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Kunnskapssenteret 4.Floor, St. Olavs Hospital, Trondheim, Norway, NO 7006. morten.thrones@ntnu.no. 3. European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway, NO 7491. 4. Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Kunnskapssenteret 4.Floor, St. Olavs Hospital, Trondheim, Norway, NO 7006. 5. Palliative Care, Pain therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Abstract
PURPOSE: Cancer pain (CP) management is challenging. In recent years, efforts were undertaken to achieve better CP management, e.g. clinical research, new treatment modalities, development of guidelines, education and focus on implementation. The aim of the present study was to compare the prevalence and characteristics of pain and breakthrough pain (BTP) between cross-sectional studies conducted in 2008 and 2014. It was hypothesized that an improvement in pain control would be observed the years in between. METHODS: Two cross-sectional studies were conducted where adult cancer patients answered questions from Brief Pain Inventory and the Alberta Breakthrough Pain Assessment Tool for cancer patients. Physicians reported socio-demographic and medical data. Regression models were applied for analysis. RESULTS: In total, 168 inpatients, 92 in 2008 and 76 in 2014, and 675 outpatients, 301 in 2008 and 374 in 2014, were included. The patient characteristics of the samples were comparable. Prevalence of CP among inpatients was 55 % in 2008 and 53 % in 2014, and among outpatients, 39 and 35 %, respectively. Inpatients reported average pain intensity (0-10 numerical rating scale, NRS) of 3.60 (standard deviation, SD 1.84) (2008) and 4.08 (SD 2.11) (2014); prevalence of BTP was 52 % (2008) and 41 % (2014). For outpatients, average pain intensity was 3.60 (SD 2.04) (2008) and 3.86 (SD 2.20) (2014); prevalence of BTP was 43 % (2008) and 37 % (2014). None of the differences were statistically significant. CONCLUSION: Unexpectedly, no improvement in pain control was observed. Efforts are still needed to improve cancer pain management.
PURPOSE:Cancer pain (CP) management is challenging. In recent years, efforts were undertaken to achieve better CP management, e.g. clinical research, new treatment modalities, development of guidelines, education and focus on implementation. The aim of the present study was to compare the prevalence and characteristics of pain and breakthrough pain (BTP) between cross-sectional studies conducted in 2008 and 2014. It was hypothesized that an improvement in pain control would be observed the years in between. METHODS: Two cross-sectional studies were conducted where adult cancerpatients answered questions from Brief Pain Inventory and the Alberta Breakthrough Pain Assessment Tool for cancerpatients. Physicians reported socio-demographic and medical data. Regression models were applied for analysis. RESULTS: In total, 168 inpatients, 92 in 2008 and 76 in 2014, and 675 outpatients, 301 in 2008 and 374 in 2014, were included. The patient characteristics of the samples were comparable. Prevalence of CP among inpatients was 55 % in 2008 and 53 % in 2014, and among outpatients, 39 and 35 %, respectively. Inpatients reported average pain intensity (0-10 numerical rating scale, NRS) of 3.60 (standard deviation, SD 1.84) (2008) and 4.08 (SD 2.11) (2014); prevalence of BTP was 52 % (2008) and 41 % (2014). For outpatients, average pain intensity was 3.60 (SD 2.04) (2008) and 3.86 (SD 2.20) (2014); prevalence of BTP was 43 % (2008) and 37 % (2014). None of the differences were statistically significant. CONCLUSION: Unexpectedly, no improvement in pain control was observed. Efforts are still needed to improve cancer pain management.
Authors: S L Du Pen; A R Du Pen; N Polissar; J Hansberry; B M Kraybill; M Stillman; J Panke; R Everly; K Syrjala Journal: J Clin Oncol Date: 1999-01 Impact factor: 44.544
Authors: Kris Vanhaecht; John Ovretveit; Martin J Elliott; Walter Sermeus; John Ellershaw; Massimiliano Panella Journal: Eval Health Prof Date: 2011-06-27 Impact factor: 2.651
Authors: M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn Journal: Ann Oncol Date: 2007-03-12 Impact factor: 32.976
Authors: Neil A Hagen; Carla Stiles; Cheryl Nekolaichuk; Patricia Biondo; Linda E Carlson; Kim Fisher; Robin Fainsinger Journal: J Pain Symptom Manage Date: 2008-01-07 Impact factor: 3.612
Authors: Morten Thronæs; Trude Rakel Balstad; Cinzia Brunelli; Erik Torbjørn Løhre; Pål Klepstad; Ola Magne Vagnildhaug; Stein Kaasa; Anne Kari Knudsen; Tora Skeidsvoll Solheim Journal: Support Care Cancer Date: 2019-07-09 Impact factor: 3.603
Authors: Ola Magne Vagnildhaug; Trude Rakel Balstad; Sigrun Saur Almberg; Cinzia Brunelli; Anne Kari Knudsen; Stein Kaasa; Morten Thronæs; Barry Laird; Tora Skeidsvoll Solheim Journal: Support Care Cancer Date: 2017-12-22 Impact factor: 3.603
Authors: Anita Amundsen; Bente Ervik; Phyllis Butow; Martin H N Tattersall; Svein Bergvik; Tore Sørlie; Tone Nordøy Journal: Support Care Cancer Date: 2016-08-19 Impact factor: 3.603
Authors: Jonas Sørensen; Per Sjøgren; Stine Novrup Clemmensen; Tanja Vibeke Sørensen; Katja Heinecke; Geana Paula Kurita Journal: Support Care Cancer Date: 2021-10-15 Impact factor: 3.603
Authors: Morten Thronæs; Erik Torbjørn Løhre; Anne Kvikstad; Elisabeth Brenne; Robin Norvaag; Kathrine Otelie Aalberg; Martine Kjølberg Moen; Gunnhild Jakobsen; Pål Klepstad; Arne Solberg; Tora Skeidsvoll Solheim Journal: Support Care Cancer Date: 2021-05-03 Impact factor: 3.603